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Abstract : All four dengue virus serotypes have occurred in French Polynesia. The first
epidemic of dengue on Tahiti island of known serotype (dengue 1) occurred in 1944 as part of
the Pacific-wide spread of the disease during World War II. The next outbreak of dengue
took place in 1964 and was the result of the introduction of dengue 3 virus. With the increase
in air travel by humans, dengue has occurred as successive epidemics, especially between 1969
and 1979 with each epidemic involving a different serotype. Each time, the epidemic serotype
replaced the unique endemic serotype that had been transmitted during the preceeding inter
-epidemic period: dengue type 3 in 1969, dengue 2 in 1971, dengue 1 in 1975-1976 and dengue
4 in 1979. With the exception of the dengue 2 epidemic, during which severe haemorrhagic
cases and several deaths were observed on Tahiti on 1971, cases of dengue haemorrhagic
fever/dengue shock syndrome (DHF/DSS) were not common. Following a long inter-epi-
demic period involving a low transmission of dengue 4, two back-to-back epidemics of
dengue 1 and dengue 3 took place during 1988-1989. Of great interest was the occurrence of
DHF/DSS in the latter epidemic (11 fatalities) while mildness characterized the former.
Surveillance of both epidemics involved clinically and laboratory-based systems. Public
health control measures were instituted. These viruses were throughoutly spread in the
Pacific region with varying degrees of disease severity. Molecular epidemiology studies
provided new information on geographic distribution, origin, evolution and strain variation
amongdengue viruses.
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HISTORICAL BACKGROUND
Dengue viruses are the only mosquito-bone flaviviruses involved in French
Polynesia･ All four dengue virus serotype have occurred in epidemic form during the last
50 years･ The first epidemic with known serotype was due to dengue 1 in 1944 as part of
the Pacific-wide pandemic (Rosen, 1958)･ The reappearance of the disease paralleled with
the advent of jet air travel and the increased urbanization of French Polynesia in the 1960's･
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Thus, a succession of epidemics occurred at short intervals : dengue 3 in 1964-1965 and
1969, dengue 1 in 1971, dengue 1 in 1975-1976, dengue 4 in 1979 (Laigret et al., 1967;
Saugrain et al., 1970 ; Moreau et al, 1973; Kaueffer et al., 1976; Pare et at., 1981a and
1981b). From 1980 to 1988, transmission of dengue continued at a very low level (Chungue
et al, 1989).
THE RECENT EpIDEMICS
Two successive epidemics took place recently : dengue 1 in late December 1988 and
dengue 3 in August 1989･ The trend and the surveillance of these epidemics have been
described in details elsewhere (Chungue et at., 1992 ; Chungue et al., 1990). Briefly,
surveillance of both epidemics was followed by ( i ) weekly reporting of the number of
patients diagnosed by sentinel physicians (a case of dengue was defined as a patient who
presented with a sudden onset of febrile illness with any of 2 of the following symptoms :
headache, myalgia, arthralgia, rash or haemorrhagic manifestations), (ii) the weekly
number of requests for laboratory confirmation, (iii) the number of virologically and/or
serologically confirmed cases (virus isolation on C6/36 cell cultures and detection of dengue
specific lgM by MAC-ELISA)･ Epidemic control involved adulticidal measures and lar-
vicidal source reduction for both epidemics. Information messages were delivered on
vector control, on minimizing risk of infection, and on the procedure to be adopted in the
event of illness･
Dengue 1 epidemic : December 1988-June 1989 : In December 1988, dengue 1 virus
was isolated from a 15 years old child who presented with a dengue-like illness. The
patient lived in a suburb of Papeete. Subsequent survey showed that 2 family contacts
harboured lgM anti dengue antibodies二　Epidemic transmission was recognized in late
December･ Although control efforts were initiated few days after, the epidemic developed
explosively and reached its peak in Tahiti island in February (Fig･ 1). The serological
attack rate was about 44%, 4 months after the onset of the epidemic. Among 6,034 cases
reported by sentinel physicians, 60.3% were<20 years old･ The illness was classical
dengue. No fatality or case of dengue haemorrhagic/dengue shock syndrome (DHF/DSS)
was reported. Of 1,752 documented cases, 701 (40%) were confirmed in laboratory･ TLe
frequency of the various clinical symptoms among these confirmed cases are shown in
Table l･ Overall, laboratory diagnosis of 4,836 patients resulted in 41% of confirmed cases
(Table 2)･ Primary infection was predominant. Virus isolation from mosquitoes pro二
vided evidence that dengue 1 was transmitted by Aedes aegypti.
Dengue 3 epidemic : August 1989-May 1989 : While the dengue 1 epidemic was
declining, dengue 3 was detected for the first time since 1969, in Bora Bora island, in mid
April. Overall 3 strains were identified between April and May･ One or them was
isolated in the neighbouring island of Raiatea･ A few cases were detected between June
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and July in Tahiti. Although French Polynesia was at high risk of epidemic dengue 3,
transmission was rather low until September (Fig･ 1)･ The peak was reached in October
-November･ The epidemic stretched out on several months, and epidemic transmission
lasted about 8 months･ As of March 1990, 6,330 cases were reported by sentinel physicians･
Of ll fatal cases, 10 occurred in children under 15 years old･ Of 838 documented cases
recorded between August to February among ambulatory patients, 266 (31･7%) were
laboratory confirmed. The frequency of clinical symptoms was shown in Table 1. The
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Fig･ 1･ Dengue 1 epidemic (Dec･ 1988二June 1989) and Dengue 3 epidemic (Aug. 1989-May
1990) : Weekly distribution of dengue cases･
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Table 2. Virological and serological results from suspected cases submitted to
laboratory confirmation of dengue diagnosis
Epidemic
No･ of No･ of positive Total





4,836　　1,198 (24.7%)　778 (16･0%)　1,976 (40.8%)
5,583　　　589 (10.5%)　768 (13･7%)　1,357 (24･3%)
hagic signs (14･3%) and the occurrence of cases severe enough to require hospitahzation･
Furthermore, cases with thrombocytopenia were high (26･3%)･ Among 232 laboratory
confirmed children hospitalized in the public civilian hospital of Papeete, 55･6% presented
with hemorrhage, 30･1% with DSS, 63% with thrombocytopenia, 46% with SCOT > 99 IU,
55% with hepatomegaly, 40 % with a neurologic disorder (Glaziou et al., 1992). Among
178 individuals for whom the type of HI antibody response was determined, 39% had a
primary infection. DSS was observed in both primary and secondary infection (41% vs
30%)･ Of 5,583 patients subjected to laboratory confirmation, 24% were confirmed (Table
2)･ This confirmation rate was low compared to that observed during dengue 1 epidemic
(41%)･ Whether this lower rate was due to clinical overdiagnosis in a context of more
severe manifestations related to dengue 3 or to the lower frequency of virus isolation since
most of cases are secondary infections, is difficult to assess･ Fur仙ermore, serological
diagnosis was mostly performed on single serum specimen and level of lgM is known to be
lower in secondary infections･ However, the serological attack rate was estimated at
about 49% in December 1989 (Chungue et al., 1992).
The study of these epidemics emphasize the need of both clinically and laboratory
-based system for an adequate surveillance of epidemic, and for early warning system･
CuRRENT SITUATION
Recent advances in dengue diagnosis : Urgent diagnosis by RT-PCR in case of
suspicion of DHF/DSS was made available since we described a rapid, simple and efficient
single-tube procedure for dengue viral RNA extraction from small amount of serum (10//1).
Recovery of RNA is based on the lysing and nuclease-inactivating properties of
guanidinium thiocyanate in the presence of silica. The RT/PCR can be completed within
5 hours starting from the RNA extraction to agarose gel electrophoresis. (Chungue et al,
1993)･
surveillance : Since 1988, the surveillance of dengue fever is based on the monitor-
ing of reported cases by physicians, of suspected cases (cases in whom a laboratory
confirmation of the diagnosis is seeked) and of confirmed cases (virologically and/or
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serologically positive)･ Moreover, because of its immediate availability, the weekly inci-
dence of suspected cases has been shown to be a valuable indicator of dengue activity
together with the confirmation rate (Chan et al., 1977 ; Chungue et al., 1991). A sudden
rise in laboratory requests urged to a号urvey among sentinel physicians.
The nature of the virus serotpype is continuously monitored･ In order to trace
movement of dengue viruses over time and geography, molecular techniques were used in
recent studies (Deubel et al., 1992). Evidence that the recent epidemics were due to the
introduction of a new variant rather than the re-emergence of early viruses through silent
transmission was shown (Chungue et al., in press). For instance, the recent Polynesian
epidemic dengue 3 virus strain clustered in a genotypic group that comprised recent strains
from Indonesia and New Caledonia･ Analysis of dengue 1 strains showed relatedness
between recent Polynesia Strain (1988) and isolate from a Caribbean strain (unpublished
data). Identification of virus strain regarding their genotypic grouping might of interest
for a better understanding of the epidemiology of dengue viruses, and for vaccine develop･
ment.
In view of continued entomological survey and vector control our effort are concen二
trated to the international airport area during interepidemic period while a community
-based vector control is promoted by the public health service, especially in Tahiti.
Situation in 1993 : Table 3 summarizes the yearly distribution of dengue cases from
1988 to 1993･ Since its introduction dengue 3 is continuously transmitted (Fig･ 2) with
sporadic severe cases (2 fatalities in 1992)･ In view of risk of epidemic dengue, when
considering the distance from the more recent known serotypes epidemics and the subse-
quent sizeable population born after them, French Polynesia is at high risk for dengue 2
epidemic, and at a lesser extent, for dengue 4 epidemic･
Table 3･ Yearly distribution of dengue cases in French Polynesia, 1988-1993
Year
Number of cases
Reported Suspected Confirmed H ospitali zed *




















a : numberreported on weeks 51 and 52 of 1988; : up to June 1993
-- : not available
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Fig. 2. Current situation : Monthly distribution of dengue 3 cases, 1989-1993･
In conclusion, improved laboratory-based surveillance, genetic investigation of
circulating viruses, disease surveillance, health education programme, vector control
programme are adopted for an efficient surveillance system.
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